Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors

NCT00563680 is registered in ClinicalTrials.gov with NantCell, Inc. as lead sponsor.

NCT NCT00563680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00563680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors
Lead sponsor
NantCell, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
August 31, 2012
Enrollment
38 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

askin's tumors, desmoplastic small round cell tumors, estraosseous ewing's tumor, ewing's family tumor, ewing's sarcoma, primitive neuroectodermal tumors (pnets), sarcoma